Loading...
Loading...
Among the 7 tracked institutional investors we monitor, CBIO (CRESCENT BIOPHARMA INC.) is held with a combined value of $97.29M across 5,493,627 shares. The largest holder is FMR LLC with a position worth $75.93M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$97.29M
Total Shares Held
5,493,627
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | FMR LLC | $75.93M | 0.00% | - |
| 2 | VANGUARD GROUP INC | $6.61M | 0.00% | New |
| 3 | MILLENNIUM MANAGEMENT LLC | $5.94M | 0.00% | +422.9% |
| 4 | Point72 Asset Management, L.P. | $5.51M | 0.01% | - |
| 5 | BlackRock, Inc. | $2.13M | 0.00% | +5.9% |
| 6 | STATE STREET CORP | $717.66K | 0.00% | +49.0% |
| 7 | RENAISSANCE TECHNOLOGIES LLC | $445.69K | 0.00% | -48.0% |
As of the latest SEC 13F filings, FMR LLC is the largest institutional holder of CBIO with a position worth $75.93M, representing 0.00% of their portfolio. In total, 7 institutional investors hold CBIO with a combined value of $97.29M.
In the most recent quarter, 1 fund opened a new position in CBIO. Additionally, 3 increased their holdings and 1 reduced their positions.
Institutional investors hold $97.29M worth of CBIO stock across 7 positions. The largest institutional holder is FMR LLC with $75.93M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For CBIO, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their CBIO positions.